Researchers have identified a small protein with a big role in lowering plasma glucose and increasing insulin sensitivity. The report indicates that Sestrin 3 plays a critical role in regulating molecular pathways that control the production of glucose and insulin sensitivity in the liver, making it a logical target for drug development for type 2 diabetes and metabolic syndrome, which can produce increased blood pressure, abnormal cholesterol levels and insulin resistance.
from Diet and Weight Loss News -- ScienceDaily http://ift.tt/1GtxBaK
Read BellyTrim XP Review: http://ift.tt/1vIh8Jg
from Diet and Weight Loss News -- ScienceDaily http://ift.tt/1GtxBaK
Read BellyTrim XP Review: http://ift.tt/1vIh8Jg
No comments:
Post a Comment